These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2138517)
61. High-frequency activation of single CD4+ and CD8+ T cells to proliferate and secrete cytokines using anti-receptor antibodies and IL-2(1). Maraskovsky E; Pech MH; Kelso A Int Immunol; 1991 Mar; 3(3):255-64. PubMed ID: 1675587 [TBL] [Abstract][Full Text] [Related]
62. Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Hirsch R; Bluestone JA; DeNenno L; Gress RE Transplantation; 1990 Jun; 49(6):1117-23. PubMed ID: 2141740 [TBL] [Abstract][Full Text] [Related]
63. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells. Cron RQ; Gajewski TF; Sharrow SO; Fitch FW; Matis LA; Bluestone JA J Immunol; 1989 Jun; 142(11):3754-62. PubMed ID: 2523934 [TBL] [Abstract][Full Text] [Related]
65. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment. Blazar BR; Hirsch R; Gress RE; Carroll SF; Vallera DA J Immunol; 1991 Sep; 147(5):1492-503. PubMed ID: 1831826 [TBL] [Abstract][Full Text] [Related]
66. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway. Ferran C; Dy M; Sheehan K; Schreiber R; Grau G; Bluestone J; Bach JF; Chatenoud L Eur J Immunol; 1991 Oct; 21(10):2349-53. PubMed ID: 1833202 [TBL] [Abstract][Full Text] [Related]
67. T cell receptor/CD3 negative variants are unresponsive to stimulation through the Ly-6 encoded molecule, TAP. Bamezai A; Reiser H; Rock KL J Immunol; 1988 Sep; 141(5):1423-8. PubMed ID: 2842394 [TBL] [Abstract][Full Text] [Related]
68. Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones. Van Seventer GA; Van Lier RA; Kuijpers KC; Spits H; Melief CJ Eur J Immunol; 1988 Dec; 18(12):1973-8. PubMed ID: 2905994 [TBL] [Abstract][Full Text] [Related]
69. Nakahara memorial lecture. Regulation of T lymphocyte responses: interactions among receptors. Fitch F; Gajewski T; Nau G; Schell S; Otten G Princess Takamatsu Symp; 1988; 19():15-27. PubMed ID: 2978617 [TBL] [Abstract][Full Text] [Related]
70. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity. Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651 [TBL] [Abstract][Full Text] [Related]
72. CD4-CD8- human T cells: phenotypic heterogeneity and activation requirements of freshly isolated "double-negative" T cells. Bender A; Kabelitz D Cell Immunol; 1990 Jul; 128(2):542-54. PubMed ID: 2141552 [TBL] [Abstract][Full Text] [Related]
73. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation. Tohma S; Hirohata S; Lipsky PE J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945 [TBL] [Abstract][Full Text] [Related]
74. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Anel A; Buferne M; Boyer C; Schmitt-Verhulst AM; Golstein P Eur J Immunol; 1994 Oct; 24(10):2469-76. PubMed ID: 7523141 [TBL] [Abstract][Full Text] [Related]
75. Evidence for involvement of the gamma, delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones. Rivas A; Koide J; Cleary ML; Engleman EG J Immunol; 1989 Mar; 142(6):1840-6. PubMed ID: 2466078 [TBL] [Abstract][Full Text] [Related]
76. Modulatory effect of aggregating the CD3 molecular complex on T cell activation. Gur H; Wacholtz MC; Davis LS; Geppert TD; Lipsky PE Cell Immunol; 1992 Mar; 140(1):81-96. PubMed ID: 1531456 [TBL] [Abstract][Full Text] [Related]
77. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4. Eichmann K; Jönsson JI; Falk I; Emmrich F Eur J Immunol; 1987 May; 17(5):643-50. PubMed ID: 3108015 [TBL] [Abstract][Full Text] [Related]
78. Activation of T lymphocytes by immobilized monoclonal antibodies to CD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants. Geppert TD; Lipsky PE J Clin Invest; 1988 May; 81(5):1497-505. PubMed ID: 2452835 [TBL] [Abstract][Full Text] [Related]
79. Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A-mediated phosphorylation of phospholipase C-gamma 1. Alava MA; DeBell KE; Conti A; Hoffman T; Bonvini E Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):189-99. PubMed ID: 1318020 [TBL] [Abstract][Full Text] [Related]
80. Generation and functional characterization of anti-clonotype antibodies to human T-cell receptors. Steenbakkers PG; Boots AM; Rijnders AW J Immunol Methods; 1997 Dec; 210(1):51-64. PubMed ID: 9502584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]